What Monash IVF does

Monash IVF is a leading Australian fertility services provider operating 112 clinic locations across metropolitan and regional Australia. Founded in 1972 as one of Australia's pioneering IVF programs, the company has helped bring over 70,000 babies into the world over 50+ years. Its service portfolio spans the full reproductive journey: assisted reproductive technologies (IVF, ICSI, IUI), fertility preservation (egg and sperm freezing), donor programs (sperm, eggs, embryos), surrogacy, genetic testing (PGT-M, PGT-A, NIPT/nest, carrier screening), and complementary care including psychological support and acupuncture.

The technology platform centers on a purpose-built flagship laboratory at Cremorne (Melbourne) featuring time-lapse embryo monitoring incubators and Piezo-ICSI technology, alongside proprietary R&D including a wearable hormone biosensor in development with Symex Labs targeting early 2028 commercialisation. Monash IVF pioneered egg vitrification and achieved the world's first birth from a vitrified egg in 1999, and its Cremorne clinic reports a 46% pregnancy rate for frozen embryo transfers vs. <40% national average (ANZARD), with 52% for patients aged 35-39. Clinical leadership comprises multiple CREI-subspecialist qualified fertility specialists led by Group Medical Director Prof Luk Rombauts and Chief Scientific Officer Prof Deirdre Zander-Fox.

Monash IVF generates revenue primarily through fee-for-service fertility treatments, specialist consultations, fertility health checks, and ancillary services such as ultrasound and genetic testing. Pricing is personalised rather than publicly listed, with Medicare rebates available for eligible patients and financing options including Zip Money, TLC Payment Plans, and superannuation access. Go-to-market combines direct-to-consumer digital marketing, a free nurse enquiry team (1800 628 533), GP and medical professional referrals, webinars and events, and on-site specialist consultations across its clinic network, targeting individuals and couples experiencing infertility, LGBTQIA+ families, single individuals, women delaying parenthood, and Queensland public servants with new Reproductive Health Leave entitlements.

Name

Monash IVF

Legal name

Monash IVF Group

Website

https://monashivf.com

Company type

Private

Founded year

1972

Operating status

Operating

Short description

Monash IVF is an Australian fertility services provider operating 112 clinic locations, offering IVF, ICSI, IUI, fertility preservation, donor programs, and genetic testing to individuals and couples across Australia.

Ownership category

akta.pro rank

Product category

Reproductive Healthcare and Fertility Services

NAICS

Family Planning Centers (62141), Family Planning Centers (621410)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Reproductive Endocrinology & Infertility (Endocrine) (HLAKADAI)

Keywords

• Fertility treatment services
• In vitro fertilisation
• Reproductive healthcare
• Fertility preservation
• Assisted reproductive technology

Headquarters

HQ city

Melbourne (Cremorne)

HQ country

Australia

HQ region

Oceania

Offices32 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Fertility Treatment Services: Monash IVF generates revenue primarily through providing fee-for-service fertility treatments including IVF, ICSI, IUI, egg freezing, sperm freezing, donor services, genetic testing, ovulation induction, and related procedures. Treatments are priced individually with transparent inclusions, and Medicare rebates are available for eligible patients.
2. Consultation and Specialist Services: Revenue from specialist fertility consultations, fertility health checks, telehealth appointments, and nursing enquiry services. Initial nurse chats are free; specialist consultations and fertility health checks generate revenue.
3. Payment Plans and Financing: Monash IVF offers payment options including Zip Money, TLC Payment Plans, and the ability to access superannuation for IVF treatment, providing financing solutions that may facilitate higher treatment uptake.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels10 records

Core offering

Monash IVF provides assisted reproductive technology and integrated fertility care across Australia, with core treatments including IVF, ICSI, IUI, fertility preservation (egg and sperm freezing), donor and surrogacy programs, preimplantation and prenatal genetic testing, and complementary diagnostic services (fertility health checks, AMH testing, semen analysis, ovulation induction, ultrasound). The company supports patients across the full reproductive journey, from fertility assessment and treatment through to early pregnancy care, operating 112 locations and a flagship full-service clinic at Cremorne with on-site laboratory and day hospital.

Product overview

Monash IVF is a leading Australian fertility provider offering a comprehensive, integrated fertility care platform spanning the entire reproductive journey. The core offering centres on assisted reproductive technologies (IVF, ICSI, IUI) and fertility preservation (egg freezing, sperm freezing), supported by donor programs (sperm, eggs, embryos) and surrogacy services. The portfolio includes genetic testing modules (PGT-M, PGT-A, NIPT/nest, carrier screening) and diagnostic services (fertility health checks, AMH testing, semen analysis, ultrasound). Supporting services include psychological support, complementary therapies, and patient education programs (Ready Set Baby). The organisation operates 112 locations across Australia with flagship full-service clinics featuring on-site laboratories and day hospitals. Research and innovation are embedded through initiatives like the Fertility Insights Index and partnerships for emerging technologies (hormone biosensors, Piezo-ICSI).

Differentiator

Problem solved

Functional benefit

Brands

• nest: Non-Invasive Prenatal Screening Test (NIPT) offering accurate screening for common chromosome conditions from 10 weeks of pregnancy.

Products and services

• IVF - In Vitro Fertilisation Primary fertility treatment involving ovarian stimulation, egg retrieval, laboratory fertilisation of eggs and sperm, and embryo transfer. Includes transparent inclusions and Medicare-rebate eligible components.
• ICSI - Intracytoplasmic Sperm Injection Microscopic sperm injection technique where a single sperm is injected directly into an egg to achieve fertilisation, primarily used for male-factor infertility.
• IUI - Assisted Insemination Intrauterine insemination procedure placing washed sperm directly into the uterus during ovulation, a less invasive fertility treatment option than IVF.
• Egg Freezing Fertility preservation service using vitrification to freeze and store unfertilised eggs. Monash IVF pioneered this method and achieved the world's first birth from a vitrified egg in 1999.
• Sperm Freezing Fertility preservation service for freezing and long-term storage of sperm samples for individuals and couples.
• Donor Sperm Program Donor sperm service for individuals and couples requiring donor conception, including same-sex couples and single women seeking IUI or IVF with donor sperm.
• Donor Eggs Program Donor egg service for individuals and couples unable to use their own eggs, including overseas donor egg programs for patients such as same-sex couples.
• Embryo Donation Program Donated embryo service allowing recipients to receive embryos donated by other IVF patients who have completed their families.
• Surrogacy Program Surrogacy arrangement support for individuals and couples needing a gestational carrier to build their families.
• PGT-M - Preimplantation Genetic Testing for Single Gene Conditions Preimplantation genetic testing to identify single-gene disorders such as cystic fibrosis or Huntington's disease before embryo transfer.
• PGT-A - Preimplantation Genetic Testing for Aneuploidy Preimplantation genetic testing to screen embryos for chromosomal aneuploidy to improve implantation success rates and reduce miscarriage risk.
• nest - Non-Invasive Prenatal Screening Test (NIPT) Non-invasive prenatal screening test available from 10 weeks offering accurate screening for common chromosome conditions. nest+ provides additional genome-wide insights at no extra cost, with samples analysed in Australia by experienced genetic scientists.
• Genetic Carrier Screening Population-based screening test for hundreds of genes to identify carriers of genetic conditions, available via saliva kit or blood test at partner pathology centres.
• Fertility Health Check Comprehensive fertility assessment including blood tests for six hormones and viral immunity, semen analysis, optional ultrasound, and a telehealth consultation with a fertility GP to discuss results and treatment pathways.
• AMH Blood Test Anti-Müllerian Hormone blood test to assess ovarian reserve and female fertility potential.
• Semen Analysis Laboratory analysis evaluating sperm count, size, shape, and movement to assess male fertility.
• Ovulation Induction Medication-based treatment to stimulate ovulation in women with irregular or absent ovulation cycles.
• Ultrasound Services

Quantifiable outcome

• Over 70,000 babies born through Monash IVF services since founding
• +5 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Share the DignitycoreStrategic or Co-development Partner · 13 March 2026Monash IVF has announced a company-wide partnership with women's charity Share the Dignity to ensure women, girls and people who menstruate facing hardship have access to essential period products. Monash IVF staff across the country will participate in fundraising, hygiene bag packing and other initiatives. Share the Dignity works with more than 3,000 charities and has received more than six million period product donations to date.
• Symex LabscoreStrategic or Co-development Partner · 10 March 2026Monash IVF partnered with Melbourne start-up Symex Labs to develop a world-first wearable hormone biosensor using microneedle technology to continuously monitor progesterone and estradiol levels for IVF patients. The patch will send results directly to the clinical team to determine optimal timing for egg collection or embryo transfer. First in-human pilot study expected within 12 months, commercialization planned for early 2028. Research received $2.5 million in funding from a joint initiative including Monash IVF, Australian Government, University of Melbourne's Genesis Fund, RMIT and Breakthrough Victoria.
• Monash UniversitycoreStrategic or Co-development PartnerMonash IVF is affiliated with Monash University, with Prof Luk Rombauts holding an Adjunct Clinical Professor appointment in the Department of Obstetrics and Gynaecology. The partnership includes plans for an Australian-first mitochondrial donation clinical trial at the Cremorne facility, pending regulatory approvals. Also research collaboration with Ritchie Centre at Monash University (Dr Luke Larmour's research background).
• Cremorne Private Day SurgerycoreStrategic or Co-development PartnerPartnership between Monash IVF and Cremorne Private Day Surgery, a purpose-built licensed day hospital at 510 Church Street, Cremorne. The facility includes a state-of-the-art laboratory, two operating theatres for fertility and gynecological procedures, and is accredited with National Safety and Quality Health Service Standards (NSQHSS).
• Ultrasound NorthminorStrategic or Co-development PartnerMonash IVF Group invested in specialist ultrasound services through the acquisition of Ultrasound North, strengthening integrated ultrasound and reproductive care network for Perth patients.
• Fertility NorthminorChannel Partner/ Reseller/ DistributorAffiliate clinic Fertility North in Joondalup (WA) through which Monash IVF offers Piezo-ICSI technology and other fertility services, extending reach to Perth's northern suburbs.
• Collingwood AFL (Darcy Cameron)minorGTM or Marketing PartnerAFL player Darcy Cameron publicly shared his experience with genetic testing through Monash IVF, encouraging prospective parents to consider testing. Represents organic community ambassador/GTM partnership through public story sharing.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Virtus Health: One of Australia's largest fertility and IVF networks with multiple clinics across Australia and Ireland; directly competes with Monash IVF on IVF, ICSI, genetic testing and fertility preservation services for the same Australian patient base.
• Genea (formerly Sydney IVF): Major Australian fertility clinic group with a strong Sydney base and multiple sites offering IVF, ICSI, preimplantation genetic testing and fertility preservation; competes head-to-head with Monash IVF in NSW and other metro markets.
• Care Fertility: UK-based fertility clinic group offering IVF, ICSI, genetic testing and donor services; comparable in service mix and patient journey to Monash IVF, providing a cross-market ART operator benchmark.
• Adora Fertility: Australian fertility clinic group operating lower-cost IVF programs; competes on price-accessible IVF cycles in the same patient demographics as Monash IVF across metro and regional Australia.
• City Fertility Centre: Australian IVF and fertility services provider with clinics across QLD, NSW, VIC and SA; offers the same core ART services, donor programs and genetic testing, targeting similar consumer patient segments.
• Shady Grove Fertility (now part of US Fertility / Inception Fertility): Large US fertility clinic network with extensive clinical and embryology services including shared-risk programmes; comparable international benchmark for scale, technology adoption and integrated reproductive care.
• Repromed (part of Genea group): Provider of fertility and IVF services across South Australia and the Northern Territory; offers standard ART and advanced reproductive technologies as an alternative provider to Monash IVF in regional markets.
• NH Diagnostics (no major listing): UK and European fertility clinic operator (TFP/The Fertility Partnership) running IVF, ICSI, donor and genetic testing programmes under a multi-clinic hub-and-spoke model that mirrors Monash IVF's Australian footprint.

Broad incumbents

• CooperSurgical (Fertility Solutions): Global medical device and fertility solutions provider offering ART lab consumables, IVF media and PGT services; overlaps with Monash IVF where its genomics and lab services intersect in the IVF workflow.
• Illumina (Reproductive and Genetic Health): Genomics platform provider enabling PGT-A, PGT-M and NIPT services used across the fertility sector; relevant adjacent comparator given Monash IVF's reliance on genetic testing as a service-line extension.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@monashivf
• Facebookfacebook.com/monashivf
• LinkedInlinkedin.com/company/monash-ivf/posts/?feedView=all
• Instagraminstagram.com/monashivf

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Monash IVF